| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |